申请人:FARMITALIA CARLO ERBA S.p.A.
公开号:EP0131301A2
公开(公告)日:1985-01-16
R, = CH3, phenyl, piperidino, 1-pyrrolidinyl, morpholino, 4-methyl-1-piperazinyl, C1-C4alkyl, C1-C4alkoxy, NH2, NHR' (R'=C1-C4alkyl, cycloalkyl, benzyl or phenyl) or NR"R'" (R" and R"' independently = C1-C4alkyll,
R2 = H, C1-C4alkyl or phenyl,
R. = F, Cn, CHF2, CBrF2, CF., CH3S, CH3SO2, NH2SO2,
C1-C4alkoxy C2-Csalkanoyl or benzoyl,
R. = C1-C4 hydrocarbon group,
R5 = H or CH3O,
R5 = H, halogen, CH3 or CH3S, and
R7 = H or CH..
The 8 α-ergoline derivatives I and their pharmaceutically acceptable salts have anorexigenic properties. Their preparation and compositions containing them are also described.
R,=
CH3、苯基、
哌啶基、1-
吡咯烷基、吗啉基、4-甲基-1-
哌嗪基、C1-C4 烷基、C1-C4 烷氧基、NH2、NHR'(R'=C1-C4 烷基、环烷基、苄基或苯基)或 NR "R'"(R "和 R"'独立 = C1-C4 烷基、
R2 = H、C1-C4 烷基或苯基、
R. = F、Cn、
CHF2、
CBrF2、CF.、 S、 SO2、NH2SO2、
C1-C4 烷氧基 C2-Csalkanoyl 或苯甲酰基、
R. = C1-C4 烃基、
R5 = H 或 O、
R5 = H、卤素、 或 S,以及
R7 = H 或 CH。
8 α-
麦角林衍
生物 I 及其药学上可接受的盐类具有厌食特性。此外,还介绍了它们的制备方法和含有它们的组合物。